lung cancer

Research in Review

Intense Tumor Lymphocytic Infiltration Predicts Improved Survival in Patients With NSCLC

02/05/2016

JCP Editors

A new study, published in the Journal of Clinical Oncology, has found that a greater presence of tumor lymphocytic infiltration (TLI) may be associated with a greater likelihood of survival in patients with non-small...

A new...

02/05/2016

Journal of Clinical Pathways

Research in Review

Population-based Study Shows No Significant Effect Of Metformin on Lung Cancer Survival

02/04/2016

JCP Editors

New evidence has revealed that metformin, a popular diabetes medication thought to inhibit the progression of lung cancer, actually has a nonsignificant effect on mortality in patients with lung...

New...

02/04/2016

Journal of Clinical Pathways

Research in Review

Higher Doses of Radiation Therapy Effective and Safe for Patients With NSCLC

02/02/2016

JCP Editors

Precision hypofractionated radiation therapy (RT) may be a potent alternative for patients with non-small cell lung cancer (NSCLC) who cannot receive chemotherapy due to the potential for severe side...

...

02/02/2016

Journal of Clinical Pathways

Research in Review

Nodal Upstaging More Common After Open Chest Surgery Than After VATS for Early-Stage Lung Cancer

01/22/2016

JCP Editors

Nodal upstaging after surgical intervention was found to be more common following open chest surgery approach to lobectomy for early-stage lung cancer compared with the closed-chest procedure known as video-assisted...

Nodal...

01/22/2016

Journal of Clinical Pathways

Research in Review

Dacomitinib Comparable to Erlotinib in Patients with EGFR+ NSCLC

01/18/2016

JCP Editors

Dacomitinib may be comparable to erlotinib in treating non-small cell lung cancer (NSCLC), specifically in patients that are positive for the epidermal growth factor receptor (EGFR) mutation. Dacomitinib, an...

...

01/18/2016

Journal of Clinical Pathways

Research in Review

Selection Criteria Barring Access to Clinical Trials for NSCLC Patients

01/15/2016

JCP Editors

Clinical trials for non–small cell lung cancer (NSCLC) are increasingly demanding tumor samples or research biopsies, which may bar participation and delay treatment for patients, a new study finds. The need for...

...

01/15/2016

Journal of Clinical Pathways

Research in Review

SERS Nanoprobes Help to Identify and Distinguish NSCLC Subtype

01/15/2016

JCP Editors

Chinese researchers have created an effective method for identifying and distinguishing non–small lung cancer (NSCLC) subtypes, utilizing nanotechnology in conjunction with statistical methods. The field of...

...

01/15/2016

Journal of Clinical Pathways

Research in Review

Statin Therapy May Improve Survival in Patients with Metastatic SCLC

01/14/2016

JCP Editors

In a retrospective study published in PLoS ONE, researchers found a survival benefit associated with statin use in patients with small cell lung cancer (SCLC) that has spread to other regions of the body. SCLC,...

In a...

01/14/2016

Journal of Clinical Pathways

Research in Review

Effectiveness of Drug for First-Line Treatment of EGFR+ Non-Small Cell Lung Cancer Supported by New Study

01/08/2016

JCP Editors

First-line treatment with erlotinib for epidermal growth factor receptor (EGFR) mutation–positive non-small cell lung cancer (NSCLC) patients may have benefits even after disease progresses, a new study...

...

01/08/2016

Journal of Clinical Pathways

Clinical Insights

Vapor Ablation for Lung Lesions: An Interview With Arschang Valipour, MD

01/03/2016

Interview by Jennifer Ford

Arschang Valipour, MD, is a chest physician and intensivist at the Otto-Wagner-Spital Department of Respiratory and Critical Care Medicine in Vienna, Austria, as well as associate professor at Medical University of Vienna. He began using the...

Arschang Valipour, MD, is a...

01/03/2016

IO Learning